INSIGHTS ON UPSTREAM MANUFACTURING
-
Maximizing Performance And Quality In Fed-Batch And Perfusion-Based IgG Productions Customer Interview
From lab to production scale: a researcher's firsthand account of what bioreactor scaling and high-density perfusion really demand in practice.
-
How MacroGenics Increased mAb Titers By Up To 80% In Scale-Up
Learn how a structured, scalable approach to process development can help improve productivity, maintain product quality, and support a smoother transition to manufacturing.
-
Industrializing Cell Therapy With Perfusion
Explore how intensified perfusion strategies enable rapid, high‑density CAR‑T expansion, predictive scale‑down modeling, and efficient automated harvest, supporting shorter timelines and higher yields.
-
Scalable Biologics Production Trends: Featuring Omar Wahab
Listen in as Dr. Corey Stanton speaks with Dr. Omar Wahab, Vice President of Bioprocessing at Lonza, about the strategic role of cell culture media in scalable biologics manufacturing.
-
From Fermentation To Vaccination4/8/2026
Non-animal-origin squalene is gaining momentum in vaccine adjuvants. See how fermentation-derived squalene delivers comparable performance, strong stability, and regulatory alignment.
-
In-Line Monitoring Of Culture Medium Using Live Cell Metabolic Analyzer4/7/2026
Continuous in-line monitoring of glucose and lactate levels provides highly accurate, real-time data on cellular metabolism without the risks or data gaps associated with manual periodic sampling.
-
The Bispecific Antibody Boom Has A Manufacturing Fix4/6/2026
Advanced cell line strategies improve stability and chain pairing while accelerating production, helping developers overcome scalability, productivity, and timeline challenges.
-
DynaDrive S.U.B. Video Series4/1/2026
Explore DynaDrive Single-Use Bioreactors through expert videos covering reactor design, mixing performance, sparge technology, and scalable workflows from bench-scale to commercial production.
UPSTREAM MANUFACTURING SOLUTIONS
-
Learn how xeno-free human dermal fibroblasts achieve over 1 billion cells in 10 days through optimized 2D and 3D expansion protocols designed for clinical-scale therapeutic manufacturing applications.
-
A concentrated bioreactor feed, RoosterReplenish-MSC-XF & prcRoosterReplenish-MSC-CC enable a fed-batch process for scalable, translation-ready cGMP hMSC manufacturing.
-
Reliable sample protection comes from secure facilities. Learn how multiple storage formats, split‑site options, and full audit trails help ensure biological materials remain ready for future use.
-
Look at how optimized virus banking strengthens manufacturing by enhancing consistency, speeding characterization timelines, and aligning testing strategies with modern regulatory expectations.
-
Reliable cell banks are essential for protecting research quality. See how expert support and structured processes help maintain cell line integrity, reduce risk, and strengthen development.